Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns
""
Newsletter

Latest Newsletters

""

Read, watch, share

Newsletter cover image
Newsletter
Newsletter |
23 July 2021
COVID-19

#NoCovidMonopolies. Thank you for helping us shape history!

In Portel, MSF teams developed activities in the rural areas where people struggle to access basic medical care. During the longest mobile clinic, through the Anapu river, activities lasted 8 days and our teams visited 4 communities. MSF treated 390 patients.
Newsletter
Newsletter |
22 June 2021
COVID-19

Share vaccine knowledge to save lives!

Pharma guidelines dictate that most forms of insulin must be stored in a fridge, and once opened, kept below 25°C. But MSF research shows that insulin can be stored in temperatures that reach up to 37°C and remain effective. These findings will make a huge difference to the lives of people in places like Dadaab refugee camp, Kenya, where temperatures can rocket, and not everyone has home access to a refrigerator.
Newsletter
Newsletter |
25 May 2021
COVID-19

100 years since insulin was discovered: why are people still waiting for treatment?

""
Newsletter
Newsletter |
03 May 2021
COVID-19

BREAKING: Join our high-level event on the WTO IP waiver

Quote comes from MSF AC Press Release from 21st April 2021, "After encouraging statement from US on landmark COVID-19 monopoly waiver, MSF calls on all opposing countries to relent ahead of next talks"
Newsletter
Newsletter |
22 April 2021
COVID-19

TODAY: A chance to stop COVID-19 Monopolies

In March 2017, organisations from 17 European countries filed an opposition to Gilead Science's patent on the highly effective hepatitis C drug sofosbuvir. On 13th and 14th of September 2018, the hearing took e place before the European Patent Office in Munich.
Newsletter
Newsletter |
24 March 2021
COVID-19

World TB Day - FB Live: A journey with a TB survivor

Dr Christos Christou commenced his role as International President of Médecins Sans Frontières in the first week of September 2019. Before this, he held a number of roles in the field with MSF and with the Association in MSF Greece. Dr Christou joined MSF in 2002
Newsletter
Newsletter |
09 March 2021
COVID-19

It’s time: Choose humanity, choose solidarity

Wealthy countries must stop standing in the way of efforts to make #COVID19 tools more available to everyone, everywhere.
Newsletter
Newsletter |
23 February 2021
COVID-19

All together now - No monopolies in a pandemic!

  • Load More
Sign up now!
Sign up to stay updated and find out how you can get involved.
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury